Thrombotic microangiopathy caused by severe graft dysfunction after living donor liver transplantation: Report of a case

Clinical Journal of Gastroenterology

Volumn 7, Issue 2, 2014, Pages 159-163

  Matsuda, Daisuke ^a   Toshima, Takeo ^a   Ikegami, Toru ^a   Harimoto, Norifumi ^a   Yamashita, Yo Ichi ^a   Yoshizumi, Tomoharu ^a   Soejima, Yuji ^a   Ikeda, Tetsuo ^a   Shirabe, Ken ^a   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Graft dysfunction; Living donor liver transplantation; Plasma exchange; Thrombotic microangiopathy

Indexed keywords

ALBUMIN; BILIRUBIN; CALCINEURIN INHIBITOR; CYCLOSPORIN; DOPAMINE; FRESH FROZEN PLASMA; HEMOGLOBIN; INFUSION FLUID; LACTATE DEHYDROGENASE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS; THROMBOCYTE CONCENTRATE; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ACUTE KIDNEY FAILURE; ADULT; ANEMIA; ARTICLE; ASCITES; BILIRUBIN BLOOD LEVEL; BLOOD GAS ANALYSIS; BRAIN DISEASE; CASE REPORT; CONTINUOUS HEMODIAFILTRATION; CONTINUOUS HEMODIALYSIS; END STAGE LIVER DISEASE; FEMALE; GENERAL CONDITION DETERIORATION; GENERAL CONDITION IMPROVEMENT; HEMOGLOBIN BLOOD LEVEL; HOSPITAL DISCHARGE; HUMAN; HYPERBILIRUBINEMIA; IMMUNOSUPPRESSIVE TREATMENT; INTENSIVE CARE UNIT; INTERNATIONAL NORMALIZED RATIO; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER BIOPSY; LIVER GRAFT; LIVER TRANSPLANTATION; LIVER WEIGHT; LIVING DONOR; MIDDLE AGED; OLIGURIA; OPERATION DURATION; OPERATIVE BLOOD LOSS; PLASMAPHERESIS; PLEURA EFFUSION; POSTOPERATIVE PERIOD; PRIMARY BILIARY CIRRHOSIS; PRIMARY GRAFT DYSFUNCTION; PRIORITY JOURNAL; STEROID THERAPY; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT RESPONSE; COMPLICATION; SEVERITY OF ILLNESS INDEX; THROMBOTIC MICROANGIOPATHIES;

FEMALE; HUMANS; LIVER TRANSPLANTATION; LIVING DONORS; MIDDLE AGED; PRIMARY GRAFT DYSFUNCTION; SEVERITY OF ILLNESS INDEX; THROMBOTIC MICROANGIOPATHIES;

EID: 84900321664     PISSN: 18657257     EISSN: 18657265     Source Type: Journal    
DOI: 10.1007/s12328-013-0446-2     Document Type: Article

References (16)

1. Ikegami T, Shimada M, Imura S, Arakawa Y, Nii A, Morine Y, et al. Current concept of small-for-size grafts in living donor liver transplantation. Surg Today. 2008;38:971-82.
2. Lee SG, Hwang S, Kim KH, Ahn CS, Moon DB, Ha TY, et al. Toward 300 liver transplants a year. Surg Today. 2009;39:367-73.
3. Moake JL. Thrombotic microangiopathies. N Engl J Med. 2002;22(347):589-600.
4. Ferrari S, Scheiflinger F, Rieger M, Mudde G, Wolf M, Coppo P, et al. Prognostic value of anti-ADAMTS 13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic micro-angiopathy with undetectable ADAMTS 13 activity. Blood. 2007;109:2815-22. (Pubitemid 46482076)
5. Tamura S, Sugawara Y, Matsui Y, Kishi Y, Akamatsu N, Kaneko J, et al. Thrombotic microangiopathy in living-donor liver transplantation. Transplantation. 2005;80:169-75. (Pubitemid 41061672)
6. Crawley JT, de Groot R, Xiang Y, Luken BM, Lane DA. Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor. Blood. 2011;118:3212-21.
7. Kamioka I, Nozu K, Fujita T, Kaito H, Tanaka R, Yoshiya K, et al. Prognosis and pathological characteristics of five children with non-Shiga toxin-mediated hemolytic uremic syndrome. Pediatr Int. 2007;49:196-201. (Pubitemid 46558300)
8. Trimarchi HM, Truong LD, Brennan S, Gonzalez JM, Suki WN. FK506-associated thrombotic microangiopathy: report of two cases and review of the literature. Transplantation. 1999;67:539-44. (Pubitemid 29114215)
9. Ponticelli C, Banfi G. Thrombotic microangiopathy after kidney transplantation. Transpl Int. 2006;19:789-94. (Pubitemid 44358844)
10. Ikegami T, Imai D, Wang H, Yoshizumi T, Yamashita YI, Ninomiya M, et al. D-MELD as a predictor of early graft mortality in adult-to-adult living-donor liver transplantation. Transplantation. 2013 [Epub ahead of print].
11. Ikegami T, Shirabe K, Yoshizumi T, Aishima S, Taketomi YA, Soejima Y, et al. Primary graft dysfunction after living donor liver transplantation is characterized by delayed functional hyperbilirubinemia. Am J Transplant. 2012;12:1886.
12. Nakazawa Y, Hashikura Y, Urata K, Ikegami T, Terada M, Yagi H, et al. Von Willebrand factor-cleaving protease activity in thrombotic microangiopathy after living donor liver transplantation: a case report. Liver Transpl. 2003;9:1328-33. (Pubitemid 37536804)
13. Uemura M, Tatsumi K, Matsumoto M, Fujimoto M, Matsuyama T, Ishikawa M, et al. Localization of ADAMTS13 to the stellate cells of human liver. Blood. 2005;106:922-4. (Pubitemid 41076434)
14. Kobayashi T, Wada H, Usui M, Sakurai H, Matsumoto T, Nobori T, et al. Decreased ADAMTS13 levels in patients after living donor liver transplantation. Thromb Res. 2009;124:541.
15. Kuriyama N, Isaji S, Hamada T, Kishiwada M, Ohsawa I, Usui M, et al. The cryoprotective effects of addition of activated protein C into preservation solution on small-for-size grafts in rats. Liver Transpl. 2010;16:1-11.
16. Shindoh J, Sugawara Y, Akamatsu N, Kaneko J, Tamura S, Yamashiki N, et al. Thrombotic microangiopathy after living-donor liver transplantation. Am J Transplant. 2012;12:728-36.